Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$1.86 - $3.61 $19,598 - $38,038
-10,537 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$3.19 - $4.89 $33,613 - $51,525
10,537 New
10,537 $36,000

Others Institutions Holding VRPX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Virpax Pharmaceuticals, Inc.


  • Ticker VRPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,714,600
  • Market Cap $6.09M
  • Description
  • Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...
More about VRPX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.